GregFolin

$REGN Poised to Cash In on Presidential Treatment

NASDAQ:REGN   Regeneron Pharmaceuticals, Inc.
REGN just got a big boost of exposure with Trump's treatment as a coming-out party.

The stock just held range support and broke up through sloped resistance. A move above the 50-day is likely on tap for today.

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。